Evaluation of a Moxifloxacin-Based, Isoniazid-Sparing Regimen for Tuberculosis Treatment; Pharmacokinetic Studies in the Use of Moxifloxacin for Treatment of Tuberculosis - site enrolled 202 subjects
Study 28, Study 28PK
Uganda
Completed in 2008
U.S. Centers for Disease Control & Prevention
TBTC 27
An Evaluation of the Activity and Tolerability of Moxifloxacin During the first two months of Treatment for Pulmonary Tuberculosis - site enrolled 155 subjects
